Skip to content

Stanford infectious disease experts devise a way to use finger-prick blood samples from small groups to detect typhoid in large populations.

Stanford infectious disease experts devise a way to use finger-prick blood samples from small groups to detect typhoid in large populations.

A Stanford pediatric infectious disease expert is highlighted in a new campaign to answer parents' questions about COVID-19 vaccines.

A Stanford pediatric infectious disease expert is highlighted in a new campaign to answer parents' questions about COVID-19 vaccines.

Published on

Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.

Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.

A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.

A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.

New research shows that 65% of people in the US will be partially vaccinated by July 4 — but for Hispanic and Black people, rates are lower.

New research shows that 65% of people in the US will be partially vaccinated by July 4 — but for Hispanic and Black people, rates are lower.

With COVID-19 information evolving daily, the Stanford Health Care pharmacy team had to prepare for the unexpected in its vaccine rollout.

With COVID-19 information evolving daily, the Stanford Health Care pharmacy team had to prepare for the unexpected in its vaccine rollout.

Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.

Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.

Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.

Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.

Published on

Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.

Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.

Published on

The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.

The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.

Published on

Stanford Health Care physician Megan Mahoney, MD, describes how conversations with family helped her decide to be among the first to get the COVID-19 vaccine.

Stanford Health Care physician Megan Mahoney, MD, describes how conversations with family helped her decide to be among the first to get the COVID-19 vaccine.

A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.

A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.

Published on